Literature DB >> 15298955

A population-based case-control study of the XRCC1 Arg399Gln polymorphism and susceptibility to bladder cancer.

Karl T Kelsey1, Sunyeong Park, Heather H Nelson, Margaret R Karagas.   

Abstract

Cigarette smoking is the major cause of bladder cancer. Constituents in tobacco smoke can induce oxidative DNA damage requiring base excision repair. The Arg399Gln polymorphism in the DNA base excision repair gene XRCC1 is associated with several phenotypic markers of reduced DNA repair capacity. Results from several epidemiologic studies suggest that the Arg399Gln polymorphism may influence susceptibility to several cancers including bladder cancer; however, data from large population-based studies are lacking. In a population-based case-control study from New Hampshire, we observed a reduced risk among those homozygous for the Arg399Gln XRCC1 variant polymorphism compared with those with one or two wild-type alleles (odds ratio 0.6, 95% confidence interval 0.4-1.0). There was no indication of a gene-environment interaction between cigarette smoking and the variant genotype. Our data are consistent with a potential role of the XRCC1 Arg399Gln polymorphism in bladder cancer susceptibility and further suggest that there may be DNA lesions important in bladder carcinogenesis, repaired by the base excision repair mechanism, that are not directly associated with tobacco smoking.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15298955

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  14 in total

1.  Genetic variation in the base excision repair pathway and bladder cancer risk.

Authors:  Jonine D Figueroa; Núria Malats; Francisco X Real; Debra Silverman; Manolis Kogevinas; Stephen Chanock; Robert Welch; Mustafa Dosemeci; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Gemma Castaño-Vinyals; Nathaniel Rothman; Montserrat García-Closas
Journal:  Hum Genet       Date:  2007-01-03       Impact factor: 4.132

2.  DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy.

Authors:  Angeline S Andrew; Margaret R Karagas; Heather H Nelson; Simonetta Guarrera; Silvia Polidoro; Sara Gamberini; Carlotta Sacerdote; Jason H Moore; Karl T Kelsey; Eugene Demidenko; Paolo Vineis; Giuseppe Matullo
Journal:  Hum Hered       Date:  2007-09-26       Impact factor: 0.444

3.  Functional polymorphisms in XRCC-1 and APE-1 contribute to increased apoptosis and risk of ulcerative colitis.

Authors:  Avinash Bardia; Santosh K Tiwari; Sivaram Gunisetty; Farha Anjum; Pratibha Nallari; Md Aejaz Habeeb; Aleem A Khan
Journal:  Inflamm Res       Date:  2011-12-23       Impact factor: 4.575

Review 4.  Smoking and selected DNA repair gene polymorphisms in controls: systematic review and meta-analysis.

Authors:  M Elizabeth Hodgson; Charles Poole; Andrew F Olshan; Kari E North; Donglin Zeng; Robert C Millikan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-08       Impact factor: 4.254

5.  Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma.

Authors:  Katie M Applebaum; Michael D McClean; Heather H Nelson; Carmen J Marsit; Brock C Christensen; Karl T Kelsey
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

6.  DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk.

Authors:  Angeline S Andrew; Rebecca A Mason; Karl T Kelsey; Alan R Schned; Carmen J Marsit; Heather H Nelson; Margaret R Karagas
Journal:  Toxicol Lett       Date:  2009-01-20       Impact factor: 4.372

7.  The association between XRCC1 polymorphism and laryngeal cancer susceptibility in different ethnic groups in Xinjiang, China.

Authors:  Nilipaer Alimu; Ayiheng Qukuerhan; Song Wang; Yasin Abdurehim; Pilidong Kuyaxi; Bo Zhang; Yalikun Yasheng
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01

8.  XRCC1 is required for DNA single-strand break repair in human cells.

Authors:  Reto Brem; Janet Hall
Journal:  Nucleic Acids Res       Date:  2005-05-02       Impact factor: 16.971

Review 9.  Epidemiology of urinary bladder cancer: from tumor development to patient's death.

Authors:  Cristiane Murta-Nascimento; Bernd J Schmitz-Dräger; Maurice P Zeegers; Gunnar Steineck; Manolis Kogevinas; Francisco X Real; Núria Malats
Journal:  World J Urol       Date:  2007-06       Impact factor: 3.661

10.  DNA repair gene XRCC1 polymorphisms and bladder cancer risk.

Authors:  Sei Chung Sak; Jennifer H Barrett; Alan B Paul; D Timothy Bishop; Anne E Kiltie
Journal:  BMC Genet       Date:  2007-04-10       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.